BACKGROUND: The complete removal of the cardiac sodium-calcium exchanger (NCX1) is associated with embryonic lethality, whereas its overexpression is linked to heart failure. To determine whether or not a reduced expression of NCX1 is compatible with normal heart structure and function, we studied 2 knockout (KO) mouse models with reduced levels of NCX1: a heterozygous global KO (HG-KO) with a 50% level of NCX1 expression in all myocytes, and a ventricular-specific KO (V-KO) with NCX1 expression in only 10% to 20% of the myocytes. METHODS AND RESULTS: Both groups of mice were evaluated at baseline, after transaortic constriction (TAC), and after acute or chronic beta-adrenergic stimulation. At baseline, the HG-KO mice had smaller hearts and the V-KO mice had larger hearts than their wild-type (WT) controls (P < .05). The HG-KO and their control WT mice had normal responses to TAC and beta-adrenergic stimulation. However, the V-KO group was intolerant to TAC and had a significantly (P < .05) blunted response to beta-adrenergic stimulation as compared with the HG-KO mice and WT controls. Unlike the HG-KO mice, the V-KO mice did not tolerate chronic isoproterenol infusion. Telemetric analysis of the electrocardiogram, body temperature, and activity revealed a normal diurnal rhythm in all groups of mice, but confirmed shorter QT intervals along with increased arrhythmias and reduced R wave to P wave amplitude ratios in the V-KO mice. CONCLUSIONS: Though NCX1 can be reduced by half in all myocytes without significant functional alterations, it must be expressed in more than 20% of the myocytes to prevent severe remodeling and heart failure in mouse heart. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: The complete removal of the cardiac sodium-calcium exchanger (NCX1) is associated with embryonic lethality, whereas its overexpression is linked to heart failure. To determine whether or not a reduced expression of NCX1 is compatible with normal heart structure and function, we studied 2 knockout (KO) mouse models with reduced levels of NCX1: a heterozygous global KO (HG-KO) with a 50% level of NCX1 expression in all myocytes, and a ventricular-specific KO (V-KO) with NCX1 expression in only 10% to 20% of the myocytes. METHODS AND RESULTS: Both groups of mice were evaluated at baseline, after transaortic constriction (TAC), and after acute or chronic beta-adrenergic stimulation. At baseline, the HG-KO mice had smaller hearts and the V-KO mice had larger hearts than their wild-type (WT) controls (P < .05). The HG-KO and their control WT mice had normal responses to TAC and beta-adrenergic stimulation. However, the V-KO group was intolerant to TAC and had a significantly (P < .05) blunted response to beta-adrenergic stimulation as compared with the HG-KO mice and WT controls. Unlike the HG-KO mice, the V-KO mice did not tolerate chronic isoproterenol infusion. Telemetric analysis of the electrocardiogram, body temperature, and activity revealed a normal diurnal rhythm in all groups of mice, but confirmed shorter QT intervals along with increased arrhythmias and reduced R wave to P wave amplitude ratios in the V-KO mice. CONCLUSIONS: Though NCX1 can be reduced by half in all myocytes without significant functional alterations, it must be expressed in more than 20% of the myocytes to prevent severe remodeling and heart failure in mouse heart. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Hannes Reuter; Scott A Henderson; Tieyan Han; Robert S Ross; Joshua I Goldhaber; Kenneth D Philipson Journal: Circ Res Date: 2002-02-22 Impact factor: 17.367
Authors: K Wakimoto; K Kobayashi; M Kuro-O; A Yao; T Iwamoto; N Yanaka; S Kita; A Nishida; S Azuma; Y Toyoda; K Omori; H Imahie; T Oka; S Kudoh; O Kohmoto; Y Yazaki; M Shigekawa; Y Imai; Y Nabeshima; I Komuro Journal: J Biol Chem Date: 2000-11-24 Impact factor: 5.157
Authors: Laila Elsherif; Michael S Huang; Shaw-Yung Shai; Yuan Yang; Rita Y Li; June Chun; Majid A Mekany; Andrew L Chu; Stephen J Kaufman; Robert S Ross Journal: Circ Res Date: 2008-03-13 Impact factor: 17.367
Authors: Kenneth P Roos; Maria C Jordan; Michael C Fishbein; Matthew R Ritter; Martin Friedlander; Helen C Chang; Paymon Rahgozar; Tieyan Han; Alejandro J Garcia; W Robb Maclellan; Robert S Ross; Kenneth D Philipson Journal: J Card Fail Date: 2007-05 Impact factor: 5.712
Authors: Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang Journal: J Physiol Date: 2016-07-31 Impact factor: 5.182
Authors: N V Ermolova; L Martinez; S A Vetrone; M C Jordan; K P Roos; H L Sweeney; M J Spencer Journal: Neuromuscul Disord Date: 2014-04-26 Impact factor: 4.296
Authors: Sanjeewa A Goonasekera; Karin Hammer; Mannix Auger-Messier; Ilona Bodi; Xiongwen Chen; Hongyu Zhang; Steven Reiken; John W Elrod; Robert N Correll; Allen J York; Michelle A Sargent; Franz Hofmann; Sven Moosmang; Andrew R Marks; Steven R Houser; Donald M Bers; Jeffery D Molkentin Journal: J Clin Invest Date: 2011-12-01 Impact factor: 14.808
Authors: N Bögeholz; P Pauls; S Kaese; J S Schulte; M D Lemoine; D G Dechering; G Frommeyer; J I Goldhaber; M D Seidl; U Kirchhefer; L Eckardt; F U Müller; C Pott Journal: J Mol Cell Cardiol Date: 2016-11-09 Impact factor: 5.000
Authors: Robert N Correll; Petra Eder; Adam R Burr; Sanda Despa; Jennifer Davis; Donald M Bers; Jeffery D Molkentin Journal: Circ Res Date: 2013-11-11 Impact factor: 17.367
Authors: Michela Ottolia; Natalia Torres; John H B Bridge; Kenneth D Philipson; Joshua I Goldhaber Journal: J Mol Cell Cardiol Date: 2013-06-12 Impact factor: 5.000